Henry Schein (NASDAQ:HSIC – Free Report) had its price target increased by Jefferies Financial Group from $77.00 to $80.00 in a research report report published on Thursday,Benzinga reports. Jefferies Financial Group currently has a hold rating on the stock.
Several other equities analysts also recently weighed in on the company. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Barrington Research restated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Evercore ISI increased their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Seven analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.30.
Get Our Latest Research Report on HSIC
Henry Schein Stock Performance
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the prior year, the firm earned $1.32 earnings per share. The firm’s revenue was up .4% compared to the same quarter last year. As a group, equities research analysts predict that Henry Schein will post 4.78 EPS for the current year.
Insider Activity
In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.14% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the company. Deroy & Devereaux Private Investment Counsel Inc. raised its stake in shares of Henry Schein by 1.1% during the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 47,550 shares of the company’s stock worth $3,290,000 after buying an additional 495 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its holdings in Henry Schein by 13.1% during the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,675 shares of the company’s stock worth $324,000 after acquiring an additional 541 shares during the period. Everett Harris & Co. CA raised its position in Henry Schein by 5.4% in the fourth quarter. Everett Harris & Co. CA now owns 156,557 shares of the company’s stock worth $10,834,000 after acquiring an additional 8,015 shares in the last quarter. Cibc World Market Inc. boosted its position in shares of Henry Schein by 2.8% during the 4th quarter. Cibc World Market Inc. now owns 360,018 shares of the company’s stock worth $24,913,000 after purchasing an additional 9,954 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. purchased a new stake in shares of Henry Schein during the 4th quarter worth $763,000. 96.62% of the stock is owned by hedge funds and other institutional investors.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- What Are Dividends? Buy the Best Dividend Stocks
- Bloom Energy: Powering the Future With Decentralized Energy
- Where Do I Find 52-Week Highs and Lows?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.